MedTrace Logo

Clinical Trial to Demonstrate the Efficacy of a Dietary Supplement in Decreasing Cardiovascular Risk

NCT03828006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-07-21

No results posted yet for this study

Summary

This clinical trial seeks to verify the efficacy of a red rice yeast dietary supplement in the decrease of cardiovascular risk, by assessing variables related with cardiovascular risk as levels of cholesterol, triglycerides and transaminases among other, in two groups of participants that will be taking either the dietary supplement or a placebo during a six months period.

Conditions

  • Low-Moderate Hypercholesterolemia

Interventions

DIETARY_SUPPLEMENT

Red Rice Yeast

Participants will take one tablet per day of a dietary supplement based on red rice yeas for a period of six months

OTHER

Placebo Group

Participants of this group will take one tablet of placebo per day for a period of six months

Sponsors & Collaborators

  • Analysis and Research Network, S.L

    collaborator OTHER

  • Bioksan

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-13
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03828006 on ClinicalTrials.gov